carbostyril has been researched along with Deafness, Transitory in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casselbrant, ML; Chonmaitree, T; Cripps, AW; Haggard, MP; Rosenfeld, RM; Schilder, AG; Venekamp, RP | 1 |
Choi, JW; Hwang, HS; Jung, YS; Kang, SU; Kim, CH; Lee, BH; Shin, YS; Song, SJ | 1 |
Anniko, M; Ohtani, M; Takumida, M | 1 |
1 review(s) available for carbostyril and Deafness, Transitory
Article | Year |
---|---|
Otitis media.
Topics: Hearing Loss; Humans; Middle Ear Ventilation; Otitis Media; Otoscopy; Pain; Quinolones; Risk Factors; Tympanic Membrane | 2016 |
1 trial(s) available for carbostyril and Deafness, Transitory
Article | Year |
---|---|
Radical scavengers for Ménière's disease after failure of conventional therapy: a pilot study.
Topics: Adult; Aged; Alanine; Antioxidants; Ascorbic Acid; Female; Free Radical Scavengers; Glutathione; Hearing Loss; Humans; Male; Meniere Disease; Middle Aged; Pilot Projects; Quinolones; Tinnitus; Treatment Failure; Vertigo | 2003 |
1 other study(ies) available for carbostyril and Deafness, Transitory
Article | Year |
---|---|
A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study.
Topics: Animals; Apoptosis; Caspase 3; Cell Line; Cisplatin; Evoked Potentials, Auditory, Brain Stem; Extracellular Signal-Regulated MAP Kinases; Female; Hearing Loss; Membrane Potential, Mitochondrial; Mice; NADPH Oxidases; Neuroprotective Agents; Organ of Corti; Quinolones; Rats, Sprague-Dawley; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Zebrafish | 2013 |